#LiverSKY

Poster by the British Liver Trust, reads 'Hepatitis... Break the Silence. Time to meet the WHO 2030 Elimination goals'

#WorldLiverDay - highlighting this essential but often overlooked organ, synonymous in different cultures with courage, growth & integrity.
We work for better outcomes in viral #hepatitis #HBV.
#MedSky #LiverSky 🧪 @britishlivertrust.bsky.social @worldhepalliance.bsky.social @easlnews.bsky.social

The May issue of @lancetgastrohep.bsky.social is out now at www.thelancet.com/gastrohep!

Content this month includes #colorectalsurgery, #colorectalcancer, #viralhepatitis + more

#GastroSky #MedSky #LiverSky #HepSky

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study Undiagnosed liver fibrosis is common in the general population in Europe and is primarily driven by metabolic factors and alcohol consumption. Early detection is pivotal as it could allow personalised interventions that can prevent progression to cirrhosis and complications.

"Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study."
Publié ce jour dans @thelancet.com
#MedSky #LiverSky
www.thelancet.com/journals/lan...

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study Undiagnosed liver fibrosis is common in the general population in Europe and is primarily driven by metabolic factors and alcohol consumption. Early detection is pivotal as it could allow personalised...

New @thelancet.com - Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study

www.thelancet.com/journals/lan...

#LiverSky #MedSky

"AASLD IDSA Practice Guideline on treatment of chronic hepatitis B."
Publié en avril dans Hepatology.
#MedSky #LiverSky
journals.lww.com/hep/fulltext...

Thank you #ISHEN @jhepatology.bsky.social
I'm happy and grateful to have participated as a panelist!
Link 👇
www.journal-of-hepatology.eu/article/S016...

#LiverSky

Peer support for people living with hepatitis B virus—A foundation for treatment expansion Chronic hepatitis B infection (CHB) affects 300 million people worldwide and is being targeted by the United Nations 2030 Sustainable Development Goals (SDGs) and the World Health Organisation (WHO),...

Our article on #PeerSupport in #HBV is a #TopCitedArticle published by J.Viral Hep in 2024. Great to know support growing for patient voice, #coproduction of #HealthCare & lived experience.
#NoHep #MedSky #LiverSky #hepatitis 🧪
@cnwl.nhs.uk @wiley.com @uclnews.bsky.social
doi.org/10.1111/jvh....

Fecal Microbiota Transplantation for Liver Disease | Docwire News Dr Tapper, Gastro Today Editorial Board Member, shares his insights into the use of fecal microbiota transplantation for liver disease.

Don't miss the commentary from @ebtapper.bsky.social on #FecalMicrobiotaTransplantation for liver disease. Dr Tapper isn't sure that we're ready to "claim victory" with #FMT just yet.
#Hepatology #GISky #LiverSky

Read the full commentary at the link:

A tribute to Dr Ahmed Elsharkawy We are deeply saddened by the passing of Dr Ahmed Elsharkawy, a dedicated trustee of the British …

In honour of @ahmedelsharkawy.bsky.social, a colleague, collaborator & friend for 25 yrs, and a wise, knowledgeable, & dedicated doctor working in support of patient voice.
Sadly missed but his legacy continues. #HBV #MedSky #LiverSky @easlnews.bsky.social
britishlivertrust.org.uk/a-tribute-to...

Alcohol-Related Liver Disease May Be More Common Than We Think After adjusting for alcohol underreporting, prevalence doubled

Alcohol-Related Liver Disease May Be More Common Than We Think

www.medpagetoday.com/gastroentero... via @medpagetoday.com

#LiverSky #MedSky

The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report Viral hepatitis represents a substantial burden of infectious disease globally, comparable with that caused by tuberculosis. Progress towards global hepatitis elimination is currently insufficient to ...

🆕 The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report

www.thelancet.com/journals/lan...

#LiverSky #IDSky #HepSky #MedSky

Photo of Institut Lumière, Lyon - which hosted our meeting. First time presenting on a cinema screen!

Viral hepatitis meeting infographic

Photo inside the auditorium with welcome to the HBV cure workshop on the big screen

Title slide ‘dialing down viraemia: diverse treatment outcomes in people living with hepatitis B’

A first trip to #Lyon this week to discuss viral #hepatitis, esp strides towards #cure (& ongoing barriers, biological, & others). Great community, lots of interesting new data, & special recognition of fabulous early career contributors
📊 🦠🧪🌍 #LiverSky
@anrs-mie.bsky.social @ice-hbv.bsky.social

Are we underestimating alcohol-related liver disease? In today's Morning Rounds newsletter: Are we underestimating alcohol-related liver disease? Plus: "Covid amnesia" and influencers promoting prescription drugs.

Are we underestimating alcohol-related liver disease?

www.statnews.com/2026/03/24/a... via @statnews.com

#LiverSky #MedSky

Long-term progression of steatotic liver disease: multiple drivers of the same disease? The steatotic liver disease1 nomenclature provides the opportunity to consider the simultaneous and synergistic contribution of alcohol consumption and cardiometabolic risk factors on disease risk and...

Linked Comment - Long-term progression of steatotic liver disease: multiple drivers of the same disease?

www.thelancet.com/journals/lan...

#LiverSky #MedSky #alcohol

Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis Adjusting for alcohol underreporting reveals a higher burden of ALD and MetALD than was previously recognised. Type 2 diabetes and binge drinking were leading mortality risk factors. These findings un...

🆕 Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis

www.thelancet.com/journals/lan...

#LiverSky #MedSky #alcohol

People with #MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 #diabetes, #cardiovascular disease, chronic #kidney disease, and extrahepatic cancers www.thelancet.com/journals/lan...
#T2D #CVD #CKD
#OpenAccess

#MedSky #EndoSky #LiverSky

The effect of alcohol minimum unit pricing and cancer warning labels on cancer incidence and mortality in Canada: an epidemiological modelling study Alcohol policies, particularly those combining pricing and labelling, could substantially reduce the cancer burden and health inequalities.

New The Lancet Public Health - The effect of alcohol minimum unit pricing and cancer warning labels on cancer incidence and mortality in Canada: an epidemiological modelling study

www.thelancet.com/journals/lan...

#GastroSky #MedSky #LiverSky

Although our HPHS meeting is over, don't fret, there's still lots of #liverpath to see at #USCAP2026 today! 😍
Platforms - 8-12, 301B
Stowell-Orbison Posters - 930-12, Hall 2
Luminaries in Pathology - 430-520, Stars at Night Ballroom B2
Evening Specialty Conference - 7-8:30, 303A
#liversky #pathsky

TONIGHT! #USCAP2026
#liverpath #pathsky #liversky

Members, don't forget to stay for our business meeting immediately after our ##USCAP2026 Companion meeting.
#liverpath #liversky #pathsky

A man (Forest Gump) running quickly to the HPHS Companion Society meeting Alt: A man (Forest Gump) running quickly to the HPHS Companion Society meeting

TODAY!
#USCAP2026
Hans Popper Hepatopathology Society companion meeting is on Sunday, March 22, 8-10 in the Stars at Night Ballroom B1 🌌
😍We'll tackle adult & pediatric cholestatic liver disease, including mimics and overlap syndrome, & pseudotumours!
#liversky #pathsky #liverpath

TOMORROW!
(Why yes, we are a little excited...)
See you there! 😁
#USCAP2026 #liversky #pathsky #liverpath

🥳🎉 As #USCAP2026 is all about making connections, we're excited to host a joint reception for members with the Rodger C Haggitt GI & Pancreaticobiliary Pathology Societies!
📆 Sunday, March 22
🗺 Marriott Hotel (Riverwalk), Alamo Ballroom, Salon C
🕝 530 - 730 pm
#pathsky #liversky #liverpath

🎉Immediately after our #USCAP2026 -HPHS meeting (Sun Mar 22, 8-10, Stars at Night Ballroom B1), members are invited to our business meeting. We will announce our abstract award winners, celebrate our lifetime achievement awardee, welcome new members, and get committee updates. #liversky #pathsky

Last but not least, Dr Mike Torbenson will address liver pseudotumours from 930-10 at our USCAP-HPHS companion meeting.
✳️ These are rare, challenging lesions - let Dr Torbenson help with diagnostic clues and ancillary studies!
#USCAP2026 #liversky #pathsky

New 📽️: Cristina López & Bryan Contreras present their findings on 9,10-DiHOME, a linoleic acid-derived #leukotoxin. This lipid mediator may increase susceptibility to bacterial infection in late-stage #cirrhosis

👉 youtu.be/9fIUZM7Df1E

#Inflammation #Immunosuppression #LiverSky
@idibaps.bsky.social

Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analy... These findings, alongside the linked systematic review and meta-analysis of antiviral treatment efficacy, supported the 2024 WHO guidelines expansion of treatment criteria to include individuals with ...

New research - Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review & meta-analysis

www.thelancet.com/journals/lan...

#LiverSky #MedSky #IDSky #HepSky

Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis Evidence supports the efficacy of nucleos(t)ide analogue therapy in adults with HBV DNA ≥20 000 IU/mL or elevated ALT. However, the efficacy of nucleos(t)ide analogues remains uncertain in adults with...

New research - Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis

www.thelancet.com/journals/lan...

#LiverSky #MedSky #IDSky #HepSky

1 week to #USCAP2026! Ready to make some connections? 🤝 We are! @uscap.org 🧡❤️
#liversky #pathsky

Then at 900-930, at our USCAP-HPHS Companion Meeting , Dr Emma Furth will guide us through mimics of biliary disease 👯
💚 Understand non-biliary diseases that mimic biliary ones and how to differentiate
#USCAP2026 #Liversky #pathsky